← All organizations
Highest phase reached
Phase 4
First clinical trial
Feb 1, 2005Last known activity
Apr 30, 2026
Timeline
1910s
- May 22, 1913
American Cancer Society, Inc.— Founded
Drugs by trial phase (47 distinct, 32 trials)
Phase 4 (3 own, 0 via acquisition)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (23 own, 0 via acquisition)
Phase 1 (16 own, 0 via acquisition)
Other trials (4 own, 0 via acquisition)
Indications
Studied for
- Arsenic Poisoning
- Breast Neoplasms
- Burkitt Lymphoma
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Squamous Cell
- Chronic Pain
- Colorectal Neoplasms
- Delirium
- Depression
- Endometrial Neoplasms
- Fatigue
- Graft vs Host Disease
- Head and Neck Neoplasms
- Hodgkin Disease
- Intraocular Lymphoma
- Keratosis
- Keratosis, Actinic
- Leukemia
- Leukemia, Biphenotypic, Acute
- Leukemia, Hairy Cell
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, Lymphoid
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Leukemia, Myeloid
- Leukemia, Myeloid, Accelerated Phase
- Leukemia, Myeloid, Acute
- Leukemia, Myeloid, Chronic-Phase
- Lung Neoplasms
- Lymphoma
- Lymphoma, B-Cell
- Lymphoma, B-Cell, Marginal Zone
- Lymphoma, Extranodal NK-T-Cell
- Lymphoma, Follicular
- Lymphoma, Large B-Cell, Diffuse
- Lymphoma, Large-Cell, Immunoblastic
- Lymphoma, Mantle-Cell
- Lymphoma, Non-Hodgkin
- Lymphomatoid Granulomatosis
- Lymphoproliferative Disorders
- Melanosis
- Multiple Myeloma
- Myelodysplastic Syndromes
- Neoplasms, Plasma Cell
- Plasmablastic Lymphoma
- Poisoning
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Preleukemia
- Prostatic Neoplasms
- Squamous Cell Carcinoma of Head and Neck
- Syndrome
- Thyroid Diseases
- Thyroid Neoplasms
- Waldenstrom Macroglobulinemia
Recent trials (32)
- NCT07265739CollaboratorPhase 2Apr 30, 2026
- NCT06934642CollaboratorEarly Phase 1Jun 30, 2025
- NCT06728072CollaboratorPhase 2Dec 15, 2024
- NCT06623630CollaboratorPhase 1Nov 30, 2024
- NCT05901545CollaboratorPhase 1Dec 31, 2023
- NCT06087328CollaboratorPhase 2Dec 5, 2023
- NCT05558904CollaboratorPhase 1/Phase 2Jan 1, 2023
- NCT04741204CollaboratorPhase 4Jun 30, 2022
- NCT04414540CollaboratorPhase 2Jul 31, 2020
- NCT04139577CollaboratorPhase 1Nov 30, 2019
- NCT03769311CollaboratorPhase 2May 8, 2019
- NCT03333746CollaboratorPhase 2Mar 21, 2018
- NCT03232892CollaboratorPhase 2Feb 13, 2018
- NCT03383835CollaboratorN/AFeb 5, 2018
- NCT01817374CollaboratorPhase 4Jun 1, 2015
Details
- Founded
- New York City, NY, US May 22, 1913
- Last known activity
- Apr 30, 2026